Cellular commitment to reentry into the cell cycle after stalled DNA is determined by site-specific phosphorylation of Chk1 and PTEN

17Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

In this study, we show that depletion of Chk1 by small interfering RNA (siRNA) results in failure of reentry to the cell cycle after DNA replication has been stalled by exposure to hydroxyurea (HU). Casein kinase II (CKII) is degraded in these cells in a proteasome-dependent manner, resulting in decreased phosphorylation and PTEN levels. We show that phosphorylation of Chk1 at Ser317 but not at Ser345 is required for phosphorylation of PTEN at Thr383 by CKII, making cell cycle reentry after HU treatment possible. Like Chk1 depletion, loss of PTEN due to siRNA is followed by inability to return to the cell cycle following HU. In Chk1-siRNA cells, reintroduction of wild-type PTEN but not PTEN T383A restores the ability of the cell to reenter the G2-M phase of the cell cycle after stalled DNA replication. We conclude that, in response to stalled DNA replication, Chk1 is phosphorylated at Ser317 by ATR resulting in stabilization of CKII, which in turn leads to phosphorylation of PTEN at Thr383. Copyright © 2008 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Martin, S. A., & Ouchi, T. (2008). Cellular commitment to reentry into the cell cycle after stalled DNA is determined by site-specific phosphorylation of Chk1 and PTEN. Molecular Cancer Therapeutics, 7(8), 2509–2516. https://doi.org/10.1158/1535-7163.MCT-08-0199

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free